Workflow guide · Landscape monitoring
How Biotech Teams Map a Competitive Target Landscape
Build a living market map that changes as programs enter, advance, fail, partner, or disappear.
The situation
When this workflow becomes useful
A biotech strategy, business development, or competitive intelligence team needs a current view of every relevant program around a target or mechanism.
Best fit
Competitive intelligence, business development, corporate strategy, clinical, regulatory, and commercial teams inside biotech and pharmaceutical companies.
The challenge
Why the obvious approach breaks down
Static landscape slides become outdated quickly. Program names, company ownership, development stages, and strategic priorities change throughout the year.
How to think about the task
The reasoning behind the workflow
A target landscape should function as a living record of competitive change. Static slides become stale when programs enter trials, change owners, report data, pause, or disappear.
The landscape needs clear inclusion rules and a change log so users can distinguish a current market map from a collection of historical company claims.
Define the scientific boundary
Specify target, mechanism, modality, indication, geography, and stage criteria. Adjacent programs can be included, but their relationship should be labeled rather than implied.
Normalize identity and ownership
Track program-code changes, company renaming, licensing, options, and acquisitions. Without ownership history, the same asset may appear twice or disappear after a transaction.
Make change the main output
Record new entry, advancement, delay, evidence, discontinuation, and transaction events. Stakeholders usually need to know what changed since the previous review, not reread the entire landscape.
Illustrative example
Illustrative quarterly landscape update
A target map contains thirty programs. During the quarter, two enter the clinic, one changes owner, three report data, and two are discontinued. The update highlights these eight changes and their implications while preserving the full source-linked table.
The strategy discussion can then focus on crowding, validation, class risk, and whitespace rather than data cleanup.
Questions to answer before making a decision
- What qualifies a program for inclusion?
- Are program identity and ownership current?
- What changed since the last review?
- Which change affects internal strategy?
The workflow
A repeatable way to do the work
- 01
Define inclusion criteria by target, modality, indication, geography, and development stage.
- 02
Normalize company names, program codes, ownership, and synonyms.
- 03
Track stage, trial design, latest evidence, next event, and source for every program.
- 04
Classify changes such as new entry, progression, delay, discontinuation, or transaction.
- 05
Review the map on a fixed cadence and after major conferences or readouts.
Monitoring checklist
Signals to keep visible
Common mistakes
- Building the landscape once for a presentation
- Ignoring synonyms and program-code changes
- Tracking stage without the evidence behind it
Output and outcome
What good looks like
Deliverable
A source-linked landscape table and change log showing who is active, what has changed, and which events are next.
Practical outcome
The team maintains a shared market view and can identify whitespace, crowding, and meaningful competitive changes earlier.
Where BioPharmSignal fits
Reduce the collection work around the decision.
Use LiveFeed and company pages for source-linked monitoring, the PDUFA Calendar for upcoming FDA milestones, and watchlists or alerts to keep the relevant tickers and keywords visible. The workflow still requires independent research and judgment.
Frequently asked questions
Who is this workflow for?
It is designed for biotech competitive intelligence teams and adjacent biotech research users who need a repeatable, source-linked way to complete this task.
What should this workflow produce?
A source-linked landscape table and change log showing who is active, what has changed, and which events are next.
What is the practical benefit?
The team maintains a shared market view and can identify whitespace, crowding, and meaningful competitive changes earlier.
Related workflows